265 related articles for article (PubMed ID: 26444110)
1. Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009-2012.
Kavanaugh ML; Jerman J; Finer LB
Obstet Gynecol; 2015 Nov; 126(5):917-927. PubMed ID: 26444110
[TBL] [Abstract][Full Text] [Related]
2. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
Ihongbe TO; Masho SW
J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
5. Long-Acting Reversible Contraception and Condom Use Among Female US High School Students: Implications for Sexually Transmitted Infection Prevention.
Steiner RJ; Liddon N; Swartzendruber AL; Rasberry CN; Sales JM
JAMA Pediatr; 2016 May; 170(5):428-34. PubMed ID: 26974492
[TBL] [Abstract][Full Text] [Related]
6. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
Allsworth JE; Secura GM; Ajibade OO; Peipert JF
J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
[TBL] [Abstract][Full Text] [Related]
7. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
[TBL] [Abstract][Full Text] [Related]
8. Who is using long-acting reversible contraceptive methods? Findings from nine low-fertility countries.
Eeckhaut MC; Sweeney MM; Gipson JD
Perspect Sex Reprod Health; 2014 Sep; 46(3):149-55. PubMed ID: 25040454
[TBL] [Abstract][Full Text] [Related]
9. Trends in long-acting reversible contraception use among U.S. women aged 15-44.
Branum AM; Jones J
NCHS Data Brief; 2015 Feb; (188):1-8. PubMed ID: 25714042
[TBL] [Abstract][Full Text] [Related]
10. Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
Moniz MH; Chang T; Heisler M; Admon L; Gebremariam A; Dalton VK; Davis MM
Obstet Gynecol; 2017 Jun; 129(6):1078-1085. PubMed ID: 28486357
[TBL] [Abstract][Full Text] [Related]
11. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010.
Moreau C; Bohet A; Hassoun D; Teboul M; Bajos N;
Fertil Steril; 2013 Aug; 100(2):451-8. PubMed ID: 23663994
[TBL] [Abstract][Full Text] [Related]
12. Familiarity with Long-acting Reversible Contraceptives among Obstetrics and Gynecology, Family Medicine, and Pediatrics Residents: Results of a 2015 National Survey and Implications for Contraceptive Provision for Adolescents.
Davis SA; Braykov NP; Lathrop E; Haddad LB
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):40-44. PubMed ID: 28942106
[TBL] [Abstract][Full Text] [Related]
13. Post-abortion initiation of long-acting reversible contraception in New Zealand.
Rose SB; Garrett SM
J Fam Plann Reprod Health Care; 2015 Jul; 41(3):197-204. PubMed ID: 25854551
[TBL] [Abstract][Full Text] [Related]
14. Satisfaction, early removal, and side effects associated with long-acting reversible contraception.
Dickerson LM; Diaz VA; Jordon J; Davis E; Chirina S; Goddard JA; Carr KB; Carek PJ
Fam Med; 2013; 45(10):701-7. PubMed ID: 24347187
[TBL] [Abstract][Full Text] [Related]
15. Peer counselling for the promotion of long-acting, reversible contraception among teens: a randomised, controlled trial.
Wilson SF; Degaiffier N; Ratcliffe SJ; Schreiber CA
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):380-7. PubMed ID: 27499054
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-month continuation of reversible contraception.
O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
[TBL] [Abstract][Full Text] [Related]
17. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.
Kortsmit K; Williams L; Pazol K; Smith RA; Whiteman M; Barfield W; Koumans E; Kourtis A; Harrison L; Bauman B; Warner L
JAMA Pediatr; 2019 Jul; 173(7):663-670. PubMed ID: 31107513
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
[No Abstract] [Full Text] [Related]
19. Factors influencing the provision of long-acting reversible contraception in California.
Biggs MA; Harper CC; Malvin J; Brindis CD
Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
[TBL] [Abstract][Full Text] [Related]
20. Three-year continuation of reversible contraception.
Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
